Successful Options Trading Begins With…
Options trading expert Wendy Kirkland’s free guide reveals the options trading principles that are as easy to implement as they are to learn and how using them could earn you thousands in extra income each month!
Download the guide here and see the difference!
Michael R.  Mcmullen net worth and biography

Michael Mcmullen Biography and Net Worth

Mike McMullen was appointed Agilent CEO in March 2015, replacing William (Bill) Sullivan.

McMullen has more than 30 years of industry experience and senior management experience at Agilent. He was president of the company's Chemical Analysis Group from 2009 until November 2014.

As head of CAG, McMullen transformed the business, consistently delivering market-leading growth and profits. He championed strategic acquisitions and architected Agilent's China strategy. He built the Agilent CrossLab Group, which includes services, software and consumables; ACG was made one of Agilent's three major businesses in September 2014. McMullen also has significant international experience, having lived in Japan, where he led Agilent's Japan field sales and support operations, later adding responsibility for China field operations. He is recognized for his inspirational leadership style.

McMullen joined Agilent's predecessor, Hewlett-Packard Co., in 1984 as a financial analyst. He holds a bachelor's degree in economics and business administration from the University of Delaware and an MBA from the Wharton School of Business. McMullen also serves on the Board of Directors for Coherent, Inc.

What is Michael R. Mcmullen's net worth?

The estimated net worth of Michael R. Mcmullen is at least $29.17 million as of July 27th, 2023. Mr. Mcmullen owns 260,869 shares of Agilent Technologies stock worth more than $29,170,372 as of October 1st. This net worth evaluation does not reflect any other assets that Mr. Mcmullen may own. Learn More about Michael R. Mcmullen's net worth.

How do I contact Michael R. Mcmullen?

The corporate mailing address for Mr. Mcmullen and other Agilent Technologies executives is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. Agilent Technologies can also be reached via phone at (800) 227-9770 and via email at [email protected]. Learn More on Michael R. Mcmullen's contact information.

Has Michael R. Mcmullen been buying or selling shares of Agilent Technologies?

Michael R. Mcmullen has not been actively trading shares of Agilent Technologies in the last ninety days. Most recently, Michael R. Mcmullen sold 944 shares of the business's stock in a transaction on Thursday, July 27th. The shares were sold at an average price of $130.00, for a transaction totalling $122,720.00. Following the completion of the sale, the chief executive officer now directly owns 260,869 shares of the company's stock, valued at $33,912,970. Learn More on Michael R. Mcmullen's trading history.

Who are Agilent Technologies' active insiders?

Agilent Technologies' insider roster includes Henrik Ancher-Jensen (SVP), Heidi Fields (Director), Rodney Gonsalves (VP), Dominique Grau (SVP), Boon Koh (Director), Padraig Mcdonnell (VP), Michael Mcmullen (CEO), Samraat Raha (VP), Michael Tang (SVP), and Jacob Thaysen (VP). Learn More on Agilent Technologies' active insiders.

Are insiders buying or selling shares of Agilent Technologies?

In the last twelve months, Agilent Technologies insiders bought shares 1 times. They purchased a total of 3 shares worth more than $333.27. In the last twelve months, insiders at the medical research company sold shares 14 times. They sold a total of 227,033 shares worth more than $34,599,589.64. The most recent insider tranaction occured on September, 28th when VP Rodney Gonsalves bought 3 shares worth more than $333.27. Learn More about insider trades at Agilent Technologies.

Information on this page was last updated on 9/28/2023.

Michael R. Mcmullen Insider Trading History at Agilent Technologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/27/2023Sell944$130.00$122,720.00260,869View SEC Filing Icon  
11/22/2022Sell128,726$155.73$20,046,499.98260,691View SEC Filing Icon  
11/16/2022Sell6,775$148.19$1,003,987.25270,896View SEC Filing Icon  
11/2/2022Sell6,775$140.61$952,632.75191,358View SEC Filing Icon  
10/26/2022Sell6,775$134.43$910,763.25191,358View SEC Filing Icon  
10/19/2022Sell6,775$130.11$881,495.25191,358View SEC Filing Icon  
12/20/2021Sell123,459$148.82$18,373,168.38View SEC Filing Icon  
4/22/2021Sell9,053$135.00$1,222,155.00261,105View SEC Filing Icon  
4/13/2021Sell8,966$132.50$1,187,995.00270,158View SEC Filing Icon  
4/8/2021Sell15,095$130.26$1,966,274.70279,124View SEC Filing Icon  
2/1/2021Sell21,212$120.26$2,550,955.12356,963View SEC Filing Icon  
12/1/2020Sell85,842$115.63$9,925,910.46415,347View SEC Filing Icon  
7/30/2020Sell72,716$95.76$6,963,284.16575,215View SEC Filing Icon  
5/8/2020Sell18,018$80.00$1,441,440.00View SEC Filing Icon  
4/29/2020Sell13,603$78.72$1,070,828.16529,245View SEC Filing Icon  
4/27/2020Sell8,814$76.20$671,626.80542,848View SEC Filing Icon  
12/10/2019Sell24,636$82.90$2,042,324.40332,121View SEC Filing Icon  
11/25/2019Sell24,636$80.00$1,970,880.00332,121View SEC Filing Icon  
9/12/2019Sell24,635$77.50$1,909,212.50View SEC Filing Icon  
3/1/2019Sell8,745$80.00$699,600.00438,939View SEC Filing Icon  
2/15/2019Sell8,746$77.67$679,301.82447,684View SEC Filing Icon  
1/30/2019Sell17,491$75.00$1,311,825.00456,430View SEC Filing Icon  
12/3/2018Sell15,923$73.20$1,165,563.60492,546View SEC Filing Icon  
1/29/2018Sell21,850$75.00$1,638,750.00324,687View SEC Filing Icon  
1/18/2018Sell21,850$72.50$1,584,125.00324,687View SEC Filing Icon  
1/5/2018Sell43,703$70.00$3,059,210.00302,837View SEC Filing Icon  
11/20/2017Sell22,481$70.00$1,573,670.00327,882View SEC Filing Icon  
11/17/2017Sell22,481$68.77$1,546,018.37336,637View SEC Filing Icon  
9/14/2017Sell16,492$65.33$1,077,422.36211,872View SEC Filing Icon  
5/23/2017Sell50,000$59.86$2,993,000.00View SEC Filing Icon  
5/1/2017Sell32,511$55.48$1,803,710.28260,346View SEC Filing Icon  
5/19/2016Sell124,411$44.46$5,531,313.06171,473View SEC Filing Icon  
4/14/2015Sell43,130$42.72$1,842,513.60View SEC Filing Icon  
6/23/2014Sell35,377$58.56$2,071,677.12View SEC Filing Icon  
6/19/2013Sell43,253$44.66$1,931,678.98View SEC Filing Icon  
See Full Table

Michael R. Mcmullen Buying and Selling Activity at Agilent Technologies

This chart shows Michael R Mcmullen's buying and selling at Agilent Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Agilent Technologies Company Overview

Agilent Technologies logo
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Read More

Today's Range

Now: $111.82
Low: $111.45
High: $113.17

50 Day Range

MA: $119.75
Low: $109.74
High: $128.46

2 Week Range

Now: $111.82
Low: $109.00
High: $160.26


1,830,120 shs

Average Volume

1,898,688 shs

Market Capitalization

$32.72 billion

P/E Ratio


Dividend Yield